Austin Area Holiday Mega Site Provides Testing at No Cost to Patients
AUSTIN, TX — November 25, 2020 — COVID-19 testing startup Curative, Inc. today announced a special holiday testing location with a new drive-thru site at Circuit of the Americas in Peppermint Parkway with up to 1,000 tests per day available at the site to residents. The site will be available during two key time frames this holiday season starting Friday, November 27th, providing COVID-19 testing site for the Austin area with no cost to patients.
“Curative is proud to deploy a drive-thru testing site on this scale and be a crucial resource for the Austin area community during a pivotal moment in this pandemic,” said Fred Turner, CEO and co-founder of Curative. “Our unique, observed and directed self-collected oral fluid swab COVID-19 PCR test offers a painless, simple option with quick 24-48-hour results and no cost to patients.”
Curative offers an oral-fluid swab testing—an alternative method to nasopharyngeal or brain swabs in testing for COVID-19. The observed and directed self-collected oral fluid swab involves having the person cough first, which releases virus from the upper and lower respiratory tract. The virus is then caught in the saliva, the patient then swabs the inside of their cheeks and the roofs of their mouths. Once complete, the patient seals their test within a secure container and returns it to a medical professional to be administered in the lab. The entire Curative test is done without having to come into close contact with others, therefore eliminating the need for personal protective equipment (PPE) changes. The sample collection process can be viewed here.
Testing is available by appointment at Circuit of the Americas starting on November 27th. Appointments are available at curative.com as well as additional information on all of Curative’s offerings.
9201 Circuit of the Americas Blvd
Austin, TX 78617
Beginning on November 27, 2020
November 27 – 29 & December 3 – 6
12pm – 8pm
Curative Inc. was founded to develop tests for sepsis in January 2020 and pivoted to COVID-19 in early March 2020 upon realizing the urgent need for test development and production in the United States. Curative is currently operational within a CLIA-certified lab in Los Angeles, CA, Washington, D.C. and Austin, TX. Founded by Fred Turner and comprised of a team of doctors, scientists, engineers, and health industry experts, Curative is rapidly scaling its simple-to-use oral fluid COVID-19 tests to reach the groups most in need of testing. For more details on Curative, please visit www.curative.com.